Your search for ‘Hyman, Phelps, & McNamara’ returned 249 results

Further talks of the Skinny Label's demise may be premature, as demonstrated by a new decision from the District Court for the District of Columbia upholding FDA's interpretation of the "same labeling" provisions of the Hatch-Waxman Amendments.

There is much change happening at FDA. In the wake of the April 1st reduction in force, there has been a great deal of uncertainty about what the impacts will be.